Berberine and rifaximin effects on small intestinal bacterial overgrowth: Study protocol for an investigator-initiated, double-arm, open-label, randomized clinical trial (BRIEF-SIBO study).
Front Pharmacol
; 14: 1121435, 2023.
Article
en En
| MEDLINE
| ID: mdl-36873985
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
/
Guideline
Idioma:
En
Revista:
Front Pharmacol
Año:
2023
Tipo del documento:
Article